GYKI-16084
Product Specifications
UNSPSC Description
GYKI-16084 is a new compound that can be isolated from dog and rat urine. GYKI-16084 can be used in the research of benign prostatic hyperplasia[1].
Target Antigen
Endogenous Metabolite
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/gyki-16084.html
Smiles
O=C1C=CC=NN1CCCNC[C@H]2OC3=CC=CC=C3OC2
Molecular Weight
301.34
References & Citations
[1]K. Migléczi, et al. Two Stage Solid Phase Extraction with Subsequent HPLC Isolation for Structure Elucidation of Major Metabolites of (+)-(R)-2-{3-(benzo[1,4]dioxan-2-yl-methylamino)-1-propyl}-3(2H)-pyridazinone (GYKI-16084). Chromatographia. 2004, 60, S67–S74.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-123710/GYKI-16084-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-123710/
Clinical Information
Phase 2
CAS Number
185739-21-3
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
